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Abstract 
The natural myocardium is a highly aligned tissue with an oriented vasculature. Its characteristic cellular as well 
as nanoscale extracellular matrix (ECM) organization along with an oriented vascular network ensures 
appropriate blood supply and functional performance. Although significant efforts have been made to develop 
anisotropic cardiac structure, currently neither an ideal biomaterial nor an effective vascularization strategy to 
engineer oriented and high-density capillary-like microvessels has been achieved for clinical cardiovascular 
therapies. A naturally derived oriented ECM nanofibrous scaffold mimics the physiological structure and 
components of tissue ECM and guides neovascular network formation. The objective of this study was to 
create an oriented and dense microvessel network with physiological myocardial microvascular features.  
Methods: Highly aligned decellularized human dermal fibroblast sheets were used as ECM scaffold to regulate 
physiological alignment of microvascular networks by co-culturing human mesenchymal stem cells (hMSCs) and 
endothelial cells (ECs). The influence of topographical features on hMSC and EC interaction was investigated to 
understand underlying mechanisms of neovasculature formation. 
Results: Results demonstrate that the ECM topography can be translated to ECs via CD166 tracks and 
significantly improved hMSC-EC crosstalk and vascular network formation. The aligned ECM nanofibers 
enhanced structure, length, and density of microvascular networks compared to randomly organized 
nanofibrous ECM. Moreover, hMSC-EC co-culture promoted secretion of pro-angiogenic growth factors and 
matrix remodeling via metalloprotease-2 (MMP-2) activation, which resulted in highly dense vascular network 
formation with intercapillary distance (20 μm) similar to the native myocardium. 
Conclusion: HMSC-EC co-culture on the highly aligned ECM generates physiologically oriented and dense 
microvascular network, which holds great potential for cardiac tissue engineering. 
Key words: Extracellular matrix nanofibers; prevascularization, vascular density, vascular maturation, vascular orientation 
Introduction 
The natural myocardium is a highly aligned 
tissue with an oriented vasculature [1, 2]. The specific 
cellular and nanoscale extracellular matrix (ECM) 
organization of the myocardium make it mechanically 
strong, while the orientation of microvessels ensure 
its effective blood supply and functional performance. 
In the past decade, significant efforts have been 
focused on developing synthetic or naturally aligned 
nanofibrous scaffolds to form an anisotropic cardiac 
structure, stimulate angiogenesis, or incorporate 
engineered microvessels to maintain tissue viability 
after implantation. However, neither an ideal 
biomaterial nor an effective vascularization strategy 
to engineer oriented capillary-like microvessels has 
yet been achieved for clinical cardiovascular 
therapies.  
Most capillaries in the heart muscle run along 
and tend to wrap around the cardiomyocytes in a 
parallel arrangement with respect to the myocardial 
fibers. Such an orientation determines the direction of 
blood flow along a particular fiber (or a group of 
fibers) [1, 2]. Therefore, it is important to create 
aligned microvessels for efficient oxygen and nutrient 
transport, and also incorporate natural inlet and 
 
Ivyspring  
International Publisher 
 Theranostics 2019, Vol. 9, Issue 8 
 
 
http://www.thno.org 
2144 
outlet sides, facilitating the anastomosis of the cardiac 
patch to the host vasculature post-implantation [3]. 
Advanced microfabrication [4-7] and 3D printing [8, 
9] show great promise in fabricating tissue constructs 
with defined microvessel structure. Unfortunately, 
these microvessels are markedly larger in diameter 
(100 µm-1mm) than native capillaries (< 10 µm) [10], 
and undoubtedly will significantly lower the 
microvessel density and constrain the blood supply 
and functional performance of the engineered cardiac 
patch after implantation. Several groups reported that 
alignment of engineered microvessels has been 
achieved via mechanical strain applied to the cellular 
constructs [3, 11-13]. Although the cardiac patch 
engraftment was significantly improved due to the 
rapid microvessel inosculation on injured 
myocardium, the dynamic cultures dramatically 
complicated the fabrication process. Moreover, the 
microvessel density was low and the patch failed in 
replicating the natural myocardium structure. 
Additionally, the materials utilized in these 
applications, as in microfabrication and 3D printing, 
are normally limited to hydrogels. Unfortunately, 
hydrogels normally cannot attain the complex 
structure, composition, and mechanical strength 
needed to match the aligned nanofibrous ECM found 
in natural myocardium.  
A variety of synthetic and natural materials have 
been developed as cardiovascular tissue substitutes. 
However, they are limited in real applications because 
their degradation products can cause adverse tissue 
reactions. Decellularized natural ECMs from native 
tissues are composed of multiple proteins interlaced 
with proteoglycans. The ECM not only serves as a 
supporting scaffold with receptor sites to orient cells, 
but also acts as a communication portal that provides 
a means for cells to interact via signaling factors to 
regulate a variety of molecular functions. 
Nevertheless, natural ECM suffers from problems of 
autologous tissue/organ scarcity, host responses, and 
pathogen transfer when allogenic and xenogenic 
tissues and organs are used [14]. Human cell-derived 
ECM scaffolds can be screened for pathogens to 
eliminate the provocation of undesirable 
inflammatory and immunological reactions from 
natural tissues and organs [14, 15]. It thus offers a 
promising alternative to ECM derived from natural 
tissues. Human dermal fibroblasts can be easily 
isolated and used to a high passage without a 
decrease in growth rate [16-18]. They also secrete 
abundant ECM biomacromolecules such as 
fibronectin, proteoglycans, collagen and elastin. 
Therefore, ECM scaffolding derived from human 
dermal fibroblast cell sheets is an attractive candidate 
for engineering a completely biological cardiac patch. 
When using a suitable substrate, such as 
Matrigel® or fibrin gel, ECs can self-assemble 
microvessels at the same order of magnitude density 
as native capillaries. Nevertheless, their structure 
experiences a post-implant regression [19]. Native 
microvessels are surrounded and stabilized by 
sparsely distributed pericytes. Similarly, supporting 
cells are required to stabilize engineered microvessels 
[20]. Mesenchymal stem cells (MSCs) can function as 
pericytes and secrete proangiogenic factors during 
tissue regeneration [21]. Moreover, MSCs are easily 
obtainable, extensively proliferative in vitro, 
immunomodulatory [22-30], and can stimulate tissue 
regeneration [23, 28, 31, 32]. Although MSCs do not 
differentiate into cardiomyocytes, the beneficial effect 
of MSCs in promoting myocardial regeneration is well 
documented. It has been shown, for example, that 
intramyocardial injection of MSCs in small animal 
models of myocardial infarction (MI) can reduce 
fibrosis and infarct size, form new cardiac tissue, 
increase capillary density, and improve cardiac 
contractility and left ventricular ejection fraction 
[33-35]. Moreover, injection of MSC sheet fragments, a 
cluster form of MSCs mixed with self-assembled 
ECM, can further improve cell retention and deliver 
cell therapy [36]. These unique properties enable 
hMSCs to combine with ECM scaffolds and ECs to 
biofabricate a prevascularized patch, in which hMSCs 
play a dual role of stabilizing vasculature formed by 
ECs in vitro and regenerating the infarcted cardiac 
tissue after implantation.  
It is important to create aligned microvessels in 
an engineered hMSC patch to biomimic the natural 
aligned myocardial capillaries and promote its 
functional performance after implantation. Although 
the role of aligned fibers in guiding cell alignment is 
well established, their effect on microvessel alignment 
is not well understood. Our group has previously 
derived a highly aligned ECM nanofibrous scaffold by 
decellularizing an aligned human dermal fibroblast 
sheet. The nanofibers are around 80 nm in their 
diameter, similar to the size of collagen nanofibers in 
vivo. Moreover, the aligned nanofibers elicited a 
reduced immune response compared their randomly 
organized nanofibrous counterpart, and could be 
repopulated with hMSCs and then stacked or rolled 
into a thick 3D structure for engineering diverse 
tissues [37, 38]. In this study, we used this aligned 
ECM nanofibrous scaffold to guide the interaction of 
hMSCs and ECs to form highly oriented microvessels 
under our previously optimized oxygen (O2) 
conditions: 7 day hMSC culture at 2% O2 followed by 
7 day hMSC-EC co-culture at 20% O2. Such a 
combination of O2 culture conditions facilitated 
hMSCs to maintain their angiogenic property, which 
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further improved the microvessels’ development and 
maturation [39-41]. Moreover, we elucidated the role 
of nanotopographical ECM organization on 
microvessel alignment, density and maturation, 
which are important considerations in the 
development of prevascularized 3D tissues. The 
prevascularized ECM scaffolds could serve as 
building blocks to fabricate a 3D prevascularized 
hMSC patch through multi-layering approaches. 
Materials and Methods 
Fabrication of aligned ECM scaffolds 
The ECM scaffolds derived from human dermal 
fibroblast sheets (ATCC, Manasass, VA) were 
prepared as previously described [42]. Briefly, aligned 
polydimethylsiloxane (PDMS) substrates were casted 
from nano-grated masters with 350 nm grating width 
and 130 nm grating depth, and coated with type I 
collage (Sigma-Aldrich, St Louis, MO). Human 
dermal fibroblasts were seeded on top of the material 
surface and cultured in Dulbecco's modified eagle 
medium (DMEM) with 20% fetal bovine serum (FBS) 
for 3 weeks with a medium change every 72 hours (h). 
The obtained cell sheets were gently peeled off from 
the PDMS layer and decellularized with 0.5% sodium 
dodecyl sulfate, 10 mM Tris (Bio-rad, Hercules, CA), 
and 25 Mm Ethylenediaminetetraacetic acid (EDTA, 
Sigma-Aldrich) solution for 15 minutes (min). After 
the decellularization process, the ECM sheets were 
thoroughly washed with PBS, followed by incubation 
in DMEM with 20% FBS, and 1% penicillin/ 
streptomycin for 48 h at room temperature to further 
decompose the remaining DNA in the ECM sheets. 
The structure of ECM nanofibers is shown in 
Supplemental Figure 1.  
ECM prevascularization  
The hMSCs were obtained from Texas A&M 
University Health Sciences Center. Passage 3 hMSCs 
at a density of 10,000 cells/cm2 were seeded on the 
decellularized ECM sheets and cultured in 
α-minimum essential medium (α-MEM) with 20% 
FBS, 1% Pen/strep, and 1% L-glutamine (Thermo 
Fisher Scientific, Waltham, MA). Following the 
optimal culture conditions we have achieved in our 
previous studies [39, 40], hMSCs were maintained 
under hypoxia (2% O2) condition for 7 days. The 
hMSCs grown on aligned ECM nanofibrous scaffold 
is shown in Supplemental Figure 1. Subsequently, the 
passage 3 human umbilical vein endothelial cells 
(HUVECs) (Lonza, Walkersville, MD), which have 
been typically used as model ECs, were seeded at a 
density of 20,000 cells/cm2 on top of the hMSCs/ECM 
constructs. The co-cultures were maintained in 
normoxia (20% O2) up to 7 days in endothelial cell 
growth media (EGM, Lonza), which was changed 
every 48 h. 
Vasculature staining and imaging 
The co-cultured prevascularized constructs were 
washed with PBS, fixed and stained with mouse 
polyclonal antibody against human CD31 (Abcam, 
Cambridge, MA), and followed by DyLight 488 horse 
anti-mouse IgG secondary antibody (Vector 
laboratories, Burlingame, CA). The samples were 
washed and incubated in 4′, 6-diamidino-2- 
phenylindole (DAPI, Sigma-Aldrich) solution to label 
the cell nuclei. Images were captured under an 
Olympus FV-1000 confocal microscope. The vascular 
networks were quantified by the ImageJ software, 
using methods previously described [43]. We firstly 
chose one vessel that aligned along the main direction 
of the nanogratings and set the angle of it as 0 degree, 
the angles of other vessels were measured and 
defined as ∆ Angle. Experiments were triplicated, and 
5 non-overlapping panels were randomly analyzed 
from each individual sample for unbiased statistical 
analysis. The same immunofluorescent staining was 
performed with anti-CD146 and anti-CD166 primary 
antibody staining. CD146 is known as the melanoma 
cell adhesion molecule (MCAM), which is regarded as 
a pericyte marker [44]. CD166 stains activated 
leukocyte cell adhesion molecule, and it was used to 
detect hMSC-EC interaction [45]. Images were 
captured under an Olympus FV-1000 confocal 
microscope by depth scan every 1 µm. The obtained 
images were reconstructed into 3-D views by a Fiji 
software. 
Enzyme-linked immunosorbent assay (ELISA) 
of soluble angiogenic growth factors 
An ELISA assay was employed to quantify 
angiogenic growth factors. The cell culture medium 
was collected from different groups at different time 
points. Growth factors in the hMSC sheet were 
extracted as previously described, and 1 mL 
extraction buffer was used for each sample [10]. The 
concentration of vascular endothelial growth factor 
(VEGF), basic fibroblast growth factor (bFGF), 
transforming growth factor beta 1 (TGF-β1), and 
angiopoietin 1 (Ang-1) were determined using ELISA 
kits (R&D Systems, Minneapolis, MN) following the 
manufacture’s protocol. Absorbance was measured 
with a plate reader (Molecular Devices, USA) at 450 
nm with correction wavelength set at 540 nm. 
Experiments were triplicated and each sample and 
standard was measured in duplicates.  
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Real-time reverse transcription polymerase 
chain reaction (RT-qPCR) 
Ribonucleic acid (RNA) was extracted using an 
RNeasy® extraction kit (Qiagen, Valencia, CA). 
Extracted RNA was reverse transcribed into cDNA 
using a reverse transcription kit (Life Technologies, 
Rockville, MD) and amplified by the StepOnePlus™ 
Real-Time PCR System (Applied Biosystems, 
Waltham, MA) using SYBR® Green Real Time PCR 
Master Mixes (Life Technology). Customized 
KiCqStart® SYBR® Green Primers (Sigma-Aldrich) 
were used, with the sequences listed in Table 1. The 
GAPDH gene was used as an endogenous control. 
Data was analyzed using the ∆∆Ct method. 
Amplification measurements were triplicated and 
three individual samples were tested for statistical 
analysis. 
Gelatin zymography for MMP-2 assessment 
Gelatin zymography was performed to assess 
matrix metalloprotease (MMP) enzymatic activity. 
Briefly, the medium was collected from different time 
points during co-culture. The collected medium from 
different groups was diluted to the same total protein 
concentration as measured by the bicinchoninic acid 
assay (BCA, Thermo Fisher Scientific). 
Polyacrylamide gels containing 4 mg / mL gelatin 
were used to separate the protein samples through 
electrophoresis. Non-reducing (beta mercaptoethanol 
free) sample buffer was used to dilute protein 
samples, and 10 µL of each sample was loaded into 
each well. Gels containing separated proteins were 
incubated for 24 h at 37 oC in incubation buffer (1% 
Triton X-100, 50 mM Tris, 5 mM CaCl2, and 1µM 
ZnCl2) to allow gelatinase reaction. Gels were then 
stained with coomassie blue (Sigma-Aldrich) staining 
solution for 30 min, followed by destaining until clear 
bands could be observed. The density of the bands 
was analyzed by imageJ. The experiment was 
triplicated for statistical analysis.  
MMP inhibition  
The MMP inhibition was performed to 
determine MMP inhibitor’s influence on the structural 
properties of microvessels. A MMP inhibitor, APR 100 
(Tocris Bioscience, Bristol, UK), was dissolved in 
dimethyl sulfoxide (DMSO) (Corning, NY) to prepare 
a 1mM stock solution. APR 100 is a selective inhibitor 
of MMP-2 (IC50 = 12 nM), which also displays 
selectivity over MMP-9, MMP-3, MMP-1 and MMP-7 
(IC50 = 200, 4500, > 50000 and > 50000 nM 
respectively). Three different working concentrations 
(1 µM, 5 µM, 10 µM) of APR 100 were prepared in 
endothelial cell growth medium (EGM), which was 
used during the 7-day co-culture. No APR 100 was 
added in the control group. After 7 days of co-culture, 
prevascularized constructs were washed with PBS, 
fixed and stained with mouse polyclonal antibody 
against human CD31 (Abcam), followed by DyLight 
488 horse anti-mouse IgG secondary antibody (Vector 
laboratories). Samples were mounted, and images 
were captured under an Olympus FV-1000 confocal 
microscope. Experiments were triplicated, and at least 
5 non-overlapping areas from each sample were 
randomly observed. 
Western blot of activated leukocyte cell 
adhesion molecule (CD166) 
Western blotting was performed on both aligned 
and random co-cultured constructs to assess the 
protein expression of CD166. Construct lysates were 
prepared using radioimmunoprecipitation assay 
(RIPA) buffer with 1% protease inhibitors (Thermo 
Fisher). Denatured cell lysates were separated by 
sodium dodecyl sulfate–polyacrylamide gel 
electrophoresis (SDS-PAGE), and transferred onto a 
polyvinylidene fluoride (PVDF) membrane. Blocking 
was performed with Tris-buffered saline (TBS) 
supplemented with 0.1% Tween-20 (TBST) (Thermo 
Fisher Scientific, Waltham, MA) and 5% dry milk 
(Bio-rad). The blocked membrane was incubated with 
the primary anti-CD166 antibody (Abcam) overnight 
at 4 °C. Horseradish peroxidase–conjugated 
secondary antibody (1:3000, Bio-rad) and enhanced 
luminol-based chemiluminescent (ECL) substrate 
(Bio-rad) was used to develop the bands. The 
developed membrane was imaged using a FluorChem 
Imaging System (Alpha InnoTech, San Leandro, CA). 
Statistical analysis 
All statistical results 
were obtained from 
triplicated experiments. 
The results were reported 
as mean ± standard 
deviation. Statistical 
comparisons between 
experimental conditions 
were performed using 
Table 1 List of primer sequences 
Common name Symbol/ Gene ID Forward sequence Reverse sequence 
GAPDH  GAPDH/2597 5′ - ACAGTTGCCATGTAGACC 5′ - TTTTTGGTTGAGCACAGG 
VEGFA  VEGFA/7422 5′ - GACCAAAGAAAGATAGAGCAAG 5′ - ATACGCTCCAGGACTTATAC 
bFGF FGF2/2247 5′ - CAAGCAGAAGAGAGAGGAG 5′ - CACTCATCCGTAACACATTTAG 
Paxillin PXN/5829 5' - ATCCTGGATAAAGTGGTGAC 5' - AAAGAAGGCTCCACACTG 
N-Cadherin CDH2/1000 5' - ACATATGTGATGACCGTAAC 5' - TTTTTCTCGATCAAGTCCAG 
Integrin α2 ITGA2/3673 5' - GGTGGGGTTAATTCAGTATG 5' - ATATTGGGATGTCTGGGATG 
Integrin β1 ITGB1/3688 5' - ATTCCCTTTCCTCAGAAGTC 5' - TTTTCTTCCATTTTCCCCTG 
MMP-2 MMP2/4313 5' - TTCTGGAGATACAATGAGGTG 5' - CTTGAAGAAGTAGCTGTGAC 
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one-way ANOVA and Tukey’s post hoc test. Results 
were considered statistically significant for p < 0.05. 
Results 
Morphology of microvascular networks 
Immunofluorescent staining of microvessels 
from aligned and random groups at different time 
points are presented in Figure 1a. The microvessel 
alignment was observed in the aligned groups 
throughout the entire co-culture period, while curves 
and swirls of vascular networks were observed in the 
random groups. Higher magnification imaging 
revealed the single vessel morphology. Similar 
structures were observed from both aligned and 
random groups at day 3. At days 5 and 7, distinct 
boundaries and tubular morphologies were observed 
in the aligned groups, while the vascular structure 
was relatively impaired in the random groups. The 
characterization of microvessels was organized in 
Figure 1(b-e). The alignment of the vascular networks 
was displayed as a boxplot (Figure 1b). The 
interquartile range (IQR), which showed the range of 
variation, was computed from the boxplot. The IQR 
values were significantly lower in the aligned groups 
(2.7 fold at day 3, 1.5 fold at day 5, and 2.2 fold at day 
7, p < 0.01), as aligned groups exhibited less variation 
in their organization compared with the wider and 
full range variation found in random groups. The 
average vessel length in aligned groups was 
significantly higher than in the random groups (1.3 
fold at day 3 and day 5, 1.2-fold at day 7, p < 0.01), and 
reached 0.23 mm at day 7 (Figure 1c). A similar trend 
was observed in total microvessel length, which was 
significantly higher in the aligned groups than their 
random counterparts (1.3 fold at day 3, 1.5 fold at day 
5, and 1.1 fold at day 7, p < 0.01, Figure 1d). The vessel 
coverage percentage was significantly higher in the 
aligned groups at day 7 (p < 0.05), with a total of 14.4% 
area covered by the vascular networks (Figure 1e). 
However, the average vessel diameter of the random 
groups was 1.3 fold wider at day 7 (p < 0.01), with 
wider vessels also observed at days 3 and 5 (p < 0.05) 
(Figure 1f). The intercapillary distance was 
significantly lower at day 5 (± 13.8 μm) and day 7 (± 
11.2 μm) (1.7 fold, p < 0.01) for the aligned groups, in 
accordance with the higher vessel density and 
coverage percentage.  
Assessment of pro-angiogenic growth factor in 
co-culture medium 
The pro-angiogenic growth factors in the 
medium from the co-culture system for both aligned 
and random groups were quantified by ELISA assay. 
Monocultures of ECs on both aligned and random 
ECM were used as controls to evaluate the 
pro-angiogenic growth factor release mediated by 
hMSCs. The background EGM concentration was also 
measured for reference. The VEGF concentration was 
significantly elevated (10 fold, p < 0.01) in the 
co-culture groups throughout the entire period, as it 
was below the EGM concentration in the monoculture 
 
Figure 1. Morphologies and characteristics of co-cultured microvascular network. (A) Immunofluorescent images of co-cultured microvascular networks at 
different time points. (B) Boxplot analysis of vessel alignment for aligned and random co-cultured groups. (C) Average vessel length. (D) Total vessel length. (E) Vessel coverage 
percentage. (F) Average vessel diameter. (G) Average intercapillary distance. The reduced interquartile measurement deviation of aligned groups indicates less vessel alignment 
variation compared to the random groups. The microvascular characterization demonstrated a denser and enhanced vascular structure in the aligned group. (*p < 0.05, **p < 
0.01) 
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groups (Figure 2a). Interestingly, at day 5, the VEGF 
concentration in the aligned culture medium 
decreased compared to the random co-culture group. 
The VEGF consumption at day 5 explains the 
increased total vascular length in the aligned 
co-culture group, as indicated in Figure 1d. Both 
co-cultures and monocultures consumed bFGF. 
Compared with monocultures, the co-cultures 
consumed additional bFGF, which was 2 fold reduced 
in the system. Aligned and random co-cultures 
consumed similar amounts of bFGF over the cell 
culture period (Figure 2b). The TGF-β1 concentration 
was slightly higher in co-cultured groups than 
monoculture groups and EGM level (Figure 2c), and 
no significant differences were identified between the 
aligned and random groups. The Ang-1 concentration 
was robustly increased to 634 pg / mL at day 3 in the 
aligned co-culture groups (2 fold higher than random 
groups, p < 0.01), and significantly dropped at days 5 
and 7 to less than 100 pg/mL. In contrast, the Ang-1 
level held steady in random groups throughout the 
entire culture period (250-300 pg/mL). It was also 
observed that the monocultures had slightly higher 
Ang-1 concentration (less than 50 pg/mL) compared 
to EGM (Figure 2d). 
Pro-angiogenic growth factors in co-cultured 
constructs 
Growth factors extracted from co-cultured 
constructs were also measured by ELISA. A higher 
concentration of VEGF was localized to the 
co-cultured groups (3 folds, p < 0.01). At day 7, only 
the aligned groups showed significant increase of 
VEGF concentration (5 fold higher than random 
groups, p < 0.01). All the other samples had a low 
localized VEGF concentration, which was lower than 
100 pg/mL. No VEGF was detected in the day 7 
random monoculture group (Figure 3a). A higher 
concentration of bFGF was found in co-cultured 
constructs relative to monocultured groups. 
Importantly, a higher bFGF concentration was 
observed in aligned co-culture groups than random 
co-cultured groups at day 5 (1.3 fold, p < 0.01) and day 
7 (1.8 fold, p < 0.01) (Figure 3b). Results of the qPCR 
analysis of VEGF and bFGF mRNA expression of 
aligned co-cultured groups were normalized to the 
random co-cultured groups. The mRNA expression 
levels of VEGF were 1.5 fold higher at day 3 and 2.3 
fold (p <0.05) higher at day 5, indicating the 
accelerated angiogenesis process before day 7. 
Following that, the VEGF mRNA was elevated in 
random co-cultured groups at day 7, denoting its 
delayed angiogenesis until day 7. The bFGF mRNA 
expression was lower for the aligned co-cultured 
groups at day 3, but was 1.2 fold higher at day 5 and 
1.5 fold higher at day 7. However, no statistical 
differences were detected for bFGF mRNA expression 
level (Figure 3c). 
 
 
Figure 2. Pro-angiogenic growth factors VEGF (A), bFGF (B), TGF-β1 (C), and Ang-1 (D) concentration in the growth medium. The background concentration of 
each factor was measured and marked as “EGM level” on each graph. The co-cultures with hMSCs secreted high level of VEGF than EC monocultures. (*p < 0.05, **p < 0.01) 
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Figure 3. Pro-angiogenic growth factors expression. (A) VEGF and (B) bFGF 
localized in the constructs assessed by ELISA. (C) The mRNA expression of VEGF 
and bFGF was measured by qRT-PCR. The aligned ECM/hMSC/EC has significantly 
more localized VEGF (day 7) and bFGF (day 5 and day 7) than the random 
ECM/MSC/EC group. (*p < 0.05, **p < 0.01) 
 
Maturation assessment through pericyte 
identification 
Immunofluorescent staining of CD146/CD31 
was performed to assess the maturation of the 
vascular structures at day 7 (Figure 4). Representative 
images demonstrated clear lumen formation in 
microvessels of aligned groups. Leading cells of the 
sprout known as ‘tip cells’ were observed in both 
groups, as shown in left images. Tip cells guide other 
ECs by sensing its surrounding environment for 
guidance cues. Aligned hMSC nuclei were observed 
at the base of the tip cell in the aligned group. In 
contrast, the tip cell in the random group followed the 
underlying hMSCs without a pre-defined direction. 
These images provided important evidence regarding 
the role of hMSCs in guiding ECs by transferring 
topographical features of the ECM. Moreover, the 
CD31 positive microvessels covered with CD146 
positive cells could be clearly identified from the 
cross-sectional view. In contrast, a flatter lumen was 
observed in the random group with less CD146 
staining around the microvessel lumen.  
Adhesion molecule mRNA expression and 
mapping 
The qPCR analysis of paxillin, N-cadherin, 
integrin α2, and integrin β1 mRNA expression of 
aligned co-cultured groups were performed and 
normalized to the random co-cultured groups (Figure 
5a). While mRNA expression was similar in paxillin at 
day 3 and day 7, day 5 paxillin expression was 
up-regulated 2 fold (no significance) in the aligned 
groups. N-cadherin mRNA expression followed the 
same trend, as the day 5 N-cadherin expression was 
enhanced 7 fold (p < 0.05) in the aligned groups. 
Integrin α2 mRNA expression was up-regulated in the 
aligned groups at day 3 (2 fold, p < 0.05) and day 5 (4.5 
fold, p < 0.05), and returned to the same level as 
random at day 7. Immunofluorescent staining of 
paxillin is presented in Figure 5b. Although red 
fluorescent paxillin positive staining was visualized 
for both aligned and random co-cultured groups, the 
paxillin expression pattern was highly aligned, 
complementing the aligned morphology of the 
vascular networks. In contrast, the vascular networks 
on the random co-cultured samples showed a random 
paxillin pattern, which followed the ECM nanofibers’ 
topography.  
Matrix remodeling activity and MMP-2 
activation 
The hMSC-secreted ECM consists of collagen I, 
collagen IV, laminin and fibronectin etc. [41]. The 
migration of ECs on top of the hMSC layer requires 
degradation of ECM components. The MMP family is 
responsible for ECM remodeling and vessel 
development, in which gelatinase MMP-2 and MMP-9 
can degrade gelatins, collagens, laminin and aggrecan 
[46]. Gelatin zymography analysis was performed to 
screen the identity of MMP during angiogenesis. 
From the gel images in Figure 6a, MMP-2 at 75 kDa 
was extensively expressed compared to MMP-9 at 92 
kDa. Whereas MMP-9 was absent from the 
co-cultured constructs. Thus, MMP-2 was identified 
as the major player, and activated MMP-2 at 68 kDa 
bands were detected as well. Activated MMP-2 
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expression was quantitatively analyzed by the band 
intensity. These results indicated that aligned 
co-cultured groups had higher activated MMP-2 
concentration at day 3 (1.5 fold, p < 0.05), which 
gradually decreased by day 7, whereas random 
co-culture groups showed gradual and significantly 
higher MMP-2 concentration (1.4 fold, p < 0.05) at day 
7 (Figure 6b). Moreover, co-culture groups showed 
higher MMP-2 concentration compared to 
monoculture groups (only ECs) in both culture 
medium and cellular constructs (Figure 6a), which 
indicated a possible role of hMSCs in MMP-2 
activation via CD166. The qPCR analysis of MMP-2 
mRNA expression of aligned co-cultured groups were 
performed and normalized to the random co-cultured 
groups. Total MMP-2 mRNA expression was similar 
between aligned and random co-cultured groups at 
days 3 and 5, but drastically increased (5.7 fold, p < 
0.01) at day 7 for the aligned co-cultured groups 
(Figure 6c), which indicated highly active matrix 
remodeling.  
To further verify the function of MMP in the 
co-culture system, a MMP inhibitor APR100 was 
introduced in the culture medium with three different 
concentrations (1 µM, 5 µM and 10 µM). It was 
observed that in the presence of APR100, especially at 
its high concentrations (5 µM and 10 µM), large 
“structural gaps” were formed in the branches of the 
microvessels, as indicated by white asterisks in Figure 
7. Whereas, in control groups, microvessels showed 
overall intact structures without such large gaps. 
Moreover, when exposed to MMP inhibition, 
microvessels showed discontinued and/or 
compromised vessel wall structure, which looked 
more like flat cellular patches rather than tubular 
structure, as indicated by white arrows. By increasing 
APR100 concentration from 1 µM to 10 µM, it was 
observed that the majority of the microvessels were 
shortened in their length along with reduced vascular 
density.  
CD166 protein expression and organization  
The western blot analysis of CD166 was 
performed on aligned and random co-cultured 
groups at different time points. Up-regulation of 
CD166 was observed at day 3 (3 fold, p < 0.05) and day 
5 (3 fold, no significance) in random co-cultured 
groups (Figure 8a). However, up-regulation of CD166 
was found in aligned co-cultured groups at day 7 (9 
fold, p < 0.05). Confocal Z-stack images displayed 
CD166 tracks on aligned co-cultured groups, which 
guided the orientation of vascular networks (Figure 
8b, arrows). No clear tracks of CD166 were observed 
on the random groups. 3D confocal imaging 
suggested that CD166 tracks localized to the bottom of 
the vascular networks, guiding the progression of the 
vessels in aligned groups. In comparison, the random 
co-cultured groups showed scattered CD166 
expression, providing no guidance to the vascular 
progression (Figure 8c). 
 
 
Figure 4. Co-immunofluorescent staining of CD146 (red) and CD31 (green) for both aligned and random groups. The microvessel was well insulated by a 
CD146 positive cell layer in the aligned group (arrows). Similarly, the cross-sectional view revealed a complete lumen by CD31 positive cells, which were covered with CD146 
positive cells. The 3D image further proved this finding in the 3D structure. 
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Figure 5. The mRNA expression of cell adhesion molecules responsible for cell-ECM interaction (A) and the morphology of paxillin (B) in both aligned and 
random samples. The aligned samples presented significantly higher mRNA expression at day 5. The paxillin were organized along the direction of hMSCs and microvessels. (*p 
< 0.05) 
 
Discussion 
Native myocardium is anisotropic, consisting 
not only of aligned cardiomyocytes, but also similarly 
aligned capillaries. It has been shown that most 
cardiomyocytes are aligned at an angle of less than 45 
degrees [47]. The capillaries between muscle cells are 
organized in the direction of muscle fibers, in order to 
fulfill interstitial oxygen and nutrient diffusion 
requirements for cell metabolism [48, 49]. The 
orientation of cells and capillaries gives rise to the 
robust density of microvasculature. In the native 
heart, the average intercapillary distance is 20 µm [50]. 
Moreover, the capillaries are wrapped by mural cells 
to ensure effective support during mass transport and 
blood flow. Therefore, an engineered myocardium 
should not only mimic the cell alignment, but also the 
capillary orientation, high density and maturity, to 
more closely mimic the architecture and support the 
functional performance of engineered tissues 
post-implantation. Although attempts have been 
made by some groups to create aligned vessels using 
micropatterning [51, 52], interstitial flow [53], and 
tensile loading [54], none of the resulting vascular 
networks are comparable with the physiological high 
alignment and density of native tissues. Aligned ECM 
nanofibers not only preserve the biomimetic 
nanofibrous topography, but also provides a 
biological niche and bioactivities of native ECM of 
target tissues [55, 56]. Such a biomimetic scaffold 
offers great opportunity for engineering an 
anisotropic cardiac patch with highly organized cells 
and capillary geometries, while generating insight 
into the mechanism of capillary formation, 
progression, and maturation.  
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Figure 6. The activity of MMPs was assessed by gelatin zymography (A), and MMP-2 was identified as the major membrane cleaving enzyme in this co-cultured angiogenesis 
system. Note that 1) the early activation of MMP-2 in aligned ECM/hMSC/EC groups and 2) the delayed MMP-2 activation in the random counterparts (B). (C) The total MMP-2 
mRNA expression was up-regulated in the aligned ECM/hMSC/EC groups at day 7. (*p < 0.05, **p < 0.01) 
 
Alignment promoted vascular network density 
and maturation  
It has been reported that an aligned topography 
provides surface guidance for EC elongation and 
motility, which can promote vascular formation in 
implantable materials [57, 58]. Several studies have 
also shown that MSC differentiation could be 
regulated by provision of topographical cues [59, 60], 
and that growth factor release profiles varied under 
different topography[61]. Those topographic cues 
included nano-scale fibers, ridges, and pores of the 
basement membrane, which were in direct contact 
with the attached cells [62]. Our results on the density 
of newly formed vasculature prove that nanofibrous 
alignment enhances vascular formation (Figure 1). 
Compared with other groups’ prevascularization 
strategies through EC/MC co-culture, our construct 
generated superior microvascular alignment, length 
and density [3, 51, 52, 61, 63]. Importantly, the average 
intercapillary distance of our aligned vascular 
networks after 5 days co-culture was below 20 μm, 
which matched the physiological intercapillary 
distance (~20 μm) that is observed in native 
myocardium [50]. Whereas in other cardiac tissue 
engineering strategies that have generated aligned 
and physiologically sized microvessels, their 
intercapillary space ranges from 50 μm to 100 μm [3, 
52]. MSCs can be recruited by neovasculature as 
pericytes to wrap the microvessels and promote their 
lumen formation and stabilization [64]. This theory 
explains the enhanced maturation of our 
prevascularized aligned groups in their 3D 
morphologies (Figure 6c), which was further 
evidenced by a layer of pericytes wrapping around 
the aligned vessels as shown by the positive CD146 
staining (Figure 4).  
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Figure 7. Influence of MMP-2/9 inhibitor APR100 on microvascular network formation. Aligned and randomly organized microvascular networks formed under 1 
µM, 5 µM and 10 µM of APR100 after 7 days of EC culture. No APR100 in the control groups. White arrows and asterisks (*) indicate the vessel walls and the structural gaps 
within microvascular networks, respectively. Both aligned and randomly organized control groups showed intact vessel wall, whereas fewer microvessels and large structural gaps 
appeared within branches of microvascular networks in MMP-inhibited samples, especially those with higher APR100 concentration. 
 
 
Figure 8. Western blot analysis (A), 2D (B) and 3D (C) morphologies of CD166 expression at different time points for both aligned and random co-culture groups. The CD166 
tracks were identified in aligned ECM/hMSC/EC groups, as identified by yellow arrows (B) The CD166 was concentrated at the interface between hMSCs and ECs in the aligned 
groups and guided the microvessels progression, while scattered CD166 expression was observed in random groups. (*p < 0.05, **p < 0.01) 
 Theranostics 2019, Vol. 9, Issue 8 
 
 
http://www.thno.org 
2154 
 
  
Figure 9. Schematic representation of aligned vascular network development by hMSC-EC co-culture on decellularized nanofibrous aligned ECM 
construct. (A) hMSCs transferred topographical features of aligned nanofibrous ECM to ECs in order to develop aligned and dense vascular network. (B) CD166-expressing 
hMSCs modulated MMP-2 activation, which further regulated directional ECM remodeling. Intercellular crosstalk between hMSCs and ECs resulted in vascular network 
formation. 
 
Topography regulated angiogenic growth 
factors in co-culture environment 
Angiogenic growth factors in cell cultures play a 
significant role in vascular network formation [65, 66]. 
hMSCs provide essential paracrine secretions 
including VEGF, bFGF, IGF-1, TGF-β, Ang-1 and HGF 
to promote EC-mediated angiogenesis [67, 68], in 
which TGF-β is a factor that promotes pericyte 
proliferation [69, 70]. In the present study, the activity 
of hMSCs could be responsible for enhanced 
expression of VEGF in both culture medium and 
co-cultured constructs compared to the EC/ECM 
monocultures (Figure 2a and 3a). The increased 
genotypic and phenotypic expression of VEGF in 
aligned co-cultures (Figure 3a, c) compared to random 
groups was consistent with the significantly 
improved microvessel density, as shown by their 
increased vessel length and vessel coverage (Figure 1). 
The bFGF concentration in cell culture medium of 
co-cultured constructs was reduced compared to 
monocultured constructs (Figure 2b). This increased 
consumption of bFGF could have contributed to the 
development of high-density capillary networks. 
However, the opposite phenomenon was observed in 
aligned cellular constructs, where bFGF expression 
was significantly increased compared to all other 
groups (Figure 3b). This significant increase in VEGF 
and bFGF expression in aligned cellular constructs 
compared to random ones was attributed to the 
topographical features. Studies have shown that 
TGF-β promotes EC quiescence and MSC 
differentiation towards pericytes during the vascular 
maturation process [21, 71-74]. Increased levels of 
TGF-β were observed in both aligned and random 
co-cultured constructs compared to monocultures, 
but no significant difference was shown (p > 0.01). The 
pericyte-like cells surrounding the microvessels could 
be attributed to the differentiation of hMSCs, causing 
by the synergized effect of bFGF and TGF-β [69], 
which resulted in higher expression of pericyte 
protein CD146 at day 7 (Figure 4). Besides TGF-β, 
angiopoietins are a major family of angiogenic growth 
factors. MSCs secrete Ang-1, especially during wound 
healing, which recruits macrophages and endothelial 
lineage cells [75-77]. Ang-1 phosphorylates the Tie-2 
receptor and this Ang-1/Tie-2 interaction regulates 
maturation of newly formed vasculature, which 
ultimately results in complex functional vascular 
network formation [78, 79]. Our previous research 
indicated that hMSCs cultured on the ECM in hypoxic 
environments promoted expression of Ang-1[39]. 
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Similarly, in this study a hypoxic environment during 
hMSCs culture on aligned ECM could be responsible 
for the initial increased expression of Ang-1 at day 3, 
which decreased gradually during normoxic 
co-culture (Figure 2d). Significantly increased levels 
of Ang-1 at day 3 in aligned co-cultures (Figure 2d) 
compared to all other groups might have led to 
development of an aligned and more matured 
vascular network. In summary, enhanced expression 
of these angiogenic factors in aligned co-cultured 
constructs compared to random constructs shows the 
effects of topographical features on microvascular 
network alignment and maturation.  
Topography guided anisotropic microvascular 
progression 
Various studies have demonstrated that matrix 
proteolytic activities can result in development of 
topographical cues in order to facilitate EC migration, 
vessel stabilization, and vessel maturation [80, 81]. 
Adhesion molecules are involved in matrix 
proteolytic events, which regulate construct 
remodeling during vascular formation. One of the 
focal adhesion molecules, paxillin, which was present 
at the ventral surface of cells, formed aligned tracks 
along the direction of aligned nanofibers and hMSCs 
(Figure 5). In addition, the mRNA of focal adhesion 
proteins was highly expressed in aligned groups. 
These organized and more intense focal adhesion sites 
could modulate and direct the migration of tip cells 
(Figure 4), which is the first important step for 
angiogenic sprouting [82]. Moreover, significantly 
higher MMP-2 was activated in aligned samples at 
early stages of angiogenic development (Figure 6a). 
CD-166 has been identified as the modulator of 
MMP-2 activation during ECM remodeling [83]. 
Investigation of matrix remodeling during 
angiogenesis indicated that the activation of MMP-2 
was dependent on the density of CD166 positive cells, 
including MSCs [84, 85]. Clear CD166 tracks were 
observed in the aligned co-culture group along with 
aligned vascular network (Figure 8b). In contrast, the 
vascular network was more aberrant on random 
nanofibrous ECM due to scattered CD166 expression 
(Figure 8b & 8c), which resulted in randomly oriented 
and less dense vascular network formation. It is thus 
possible that through CD166, the aligned 
topographical feature upregulated hMSCs’ 
capabilities for MMP-2 activation, which might have 
played a role in the increased vascular network 
density. This was verified by MMP inhibition in the 
co-culture system, where the microvessels showed a 
deteriorated vessel wall, along with shortened vessel 
length and reduced vascular density (Figure 7).  
Based on our results, potential mechanism of 
nano-topography guided angiogenesis can be 
concluded in the following steps: 1) hMSCs followed 
contact guidance that was provided by aligned ECM 
nanofibers, and formed aligned confluent hMSC layer 
in the same direction 2) CD166-expressing hMSCs 
formed vascular guiding tracks. Importantly, CD166 
mediated MMP-2 activation, and MMP-2 in turn 
mediated ECM remodeling. Activated MMP-2 
possibly helped EC migration along the aligned ECM 
nanofibers. 3) Intercellular interaction between ECs 
and MSCs promoted the pro-angiogenic factor release 
and deposition, which resulted in aligned, stable and 
mature vascular network formation, as illustrated in 
Figure 9. 
Conclusions 
In this study, we demonstrated successful 
engineering of highly oriented, dense and matured 
vascular networks on an aligned nanofibrous ECM 
construct by hMSC/EC co-culture. The ECM 
topography greatly influenced the vascular network 
development by enhancing vascular alignment, 
angiogenic growth factor secretion, and ECM 
remodeling. Importantly, our study indicated that 
hMSCs successfully translated the alignment of 
nanofibrous ECM scaffold to ECs and guided the 
microvascular structure. These prevascularized 
aligned ECM constructs with highly dense and 
mature microvascular networks could be stacked on 
each other to construct completely biological 3D tissue 
to accelerate cardiac regeneration.  
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